Browse > Article

Clinical characteristics of congenital myotonic dystrophy diagnosed by molecular genetic method  

Nam, Sook Hyun (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University school of Medicine)
Son, Young Bae (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University school of Medicine)
Lee, Bo Lyun (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University school of Medicine)
Lee, Jeehun (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University school of Medicine)
Ki, Chang-seok (Laboratory medicine, Samsung Medical Center, Sungkyunkwan University school of Medicine)
Lee, Munhyang (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University school of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.50, no.9, 2007 , pp. 868-874 More about this Journal
Abstract
Purpose : We performed this study to investigate the perinatal and developmental features of the patients with congenital myotonic dystrophy (CDM) confirmed by the molecular genetic method and the clinical characteristics of their mother, and to identify the relation between the number of CTG repeats and the clinical severity.Methods : A retrospective review of the medical records and the results of the dystrophia myotonica protein kinase (DMPK) gene test was done for the patients who were confirmed as CDM through gene analysis from January 2001 to September 2006. Results : All of the eight patients (male 2, female 6) showed moderate to severe degree of perinatal distress and feeding difficulty associated with profound hypotonia. Three patients had the history of polyhydramnios and two patients had equinovarus deformity. The developmental milestones were delayed in all patients, which improved gradually with age. All of their mothers demonstrated myotonic symptoms and typical myopathic face. The number of CTG repeats in DMPK gene analysis ranged 1,000-2,083, and there was no significant correlation between the number of CTG repeats and the time of walking alone. Conclusion : All patients with CDM presented with severe hypotonia in perinatal period, and developmental delay thereafter, which were improved with age. All of their mothers manifested myotonic symptoms with typical myopathic face, and the identification of such features greatly contributed to the diagnosis of the patients. The number of CTG repeats had no significant influence on the motor development.
Keywords
Congenital myotonic dystrophy; Polyhydramnios; Equinovarus; Hypotonia; Myotonic dystrophy protein kinase; Trinucleotide repeats;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Machuca-Tzili L, Brook D, Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve 2005;32:1-18   DOI   ScienceOn
2 Fu YH, Pizzuti A, Fenwick RG, Jr., King J, Rajnarayan S, Dunne PW, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256-8   DOI
3 Roig M, Balliu PR, Navarro C, Brugera R, Losada M. Presentation, clinical course, and outcome of the congenital form of myotonic dystrophy. Pediatr Neurol 1994;11:208-13   DOI   ScienceOn
4 Dubowitz V. Genetic counselling. Neuromuscul Disord 1992; 2:85-6   DOI   ScienceOn
5 Rudnik-Schoneborn S, Zerres K. Outcome in pregnancies complicated by myotonic dystrophy: a study of 31 patients and review of the literature. Eur J Obstet Gynecol Reprod Biol 2004;114:44-53   DOI   ScienceOn
6 Imbert G, Kretz C, Johnson K, Mandel JL. Origin of the expansion mutation in myotonic dystrophy. Nat Genet 1993; 4:72-6   DOI   ScienceOn
7 Groenen P, Wieringa B. Expanding complexity in myotonic dystrophy. Bioessays 1998;20:901-12   DOI   ScienceOn
8 Zerylnick C, Torroni A, Sherman SL, Warren ST. Normal variation at the myotonic dystrophy locus in global human populations. Am J Hum Genet 1995;56:123-30
9 Pearson CE, Nichol Edamura K, Cleary JD. Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 2005;6:729-42   DOI   ScienceOn
10 Harper PS. Myotonic Dystrophy. 2nd ed. London : W.B. Saunders, 1989:13-78
11 Jung SH, Bang MS. Belated diagnosis of congenital myotonic dystrophy in a boy with cerebral palsy. Am J Phys Med Rehabil 2007;86:161-5   DOI   ScienceOn
12 Harley HG, Rundle SA, MacMillan JC, Myring J, Brook JD, Crow S, et al. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet 1993;52:1164-74
13 Zaki M, Boyd PA, Impey L, Roberts A, Chamberlain P. Congenital myotonic dystrophy: prenatal ultrasound findings and pregnancy outcome. Ultrasound Obstet Gynecol 2007; 29:284-8   DOI   ScienceOn
14 Dubowitz V. Muscle Disorders in Childhood. 2nd ed. London: WB Saunders Co, 1995:289
15 Lueck JD, Mankodi A, Swanson MS, Thornton CA, Dirksen RT. Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy. J Gen Physiol 2007;129:79-94   DOI   ScienceOn
16 Martorell L, Cobo AM, Baiget M, Naudo M, Poza JJ, Parra J. Prenatal diagnosis in myotonic dystrophy type 1. Thirteen years of experience: implications for reproductive counselling in DM1 families. Prenat Diagn 2007;27:68-72   DOI   ScienceOn
17 Lavedan C, Hofmann-Radvanyi H, Shelbourne P, Rabes JP, Duros C, Savoy D, et al. Myotonic dystrophy: size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism. Am J Hum Genet 1993;52:875-83
18 Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992;69:385
19 Cho DH, Tapscott SJ. Myotonic dystrophy: Emerging mechanisms for DM1 and DM2. Biochim Biophys Acta 2006; 1772:195-204
20 Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 1992;255:1253-5   DOI
21 Furling D, Lam le T, Agbulut O, Butler-Browne GS, Morris GE. Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy. Am J Pathol 2003;162:1001-9   DOI   ScienceOn
22 New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). The International Myotonic Dystrophy Consortium (IDMC). Neurology 2000;54:1218-21   DOI   ScienceOn
23 Schara U, Schoser BG. Myotonic dystrophies type 1 and 2:a summary on current aspects. Semin Pediatr Neurol 2006; 13:71-9   DOI   ScienceOn
24 Kim SH, Kim EY, Park SK, Choi SJ, Lim SC. A Case of Congenital Myotonic Dystrophy Diagnosed by Molecular Genetics. J Korean Soc Neonatol 2006;13:194-8
25 Kim HK, Kim JH, Lee YA, Ko TS, Kim KS, Yoo HW, et al. A Case of Congenital Myotonic Dystrophy Diagnosed by Molecular Genetics. J Korean Child Neurol Soc 1998;5:356- 60
26 Arsenault ME, Prevost C, Lescault A, Laberge C, Puymirat J, Mathieu J. Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions. Neurology 2006;66:1248-50   DOI   ScienceOn
27 Day JW, Ranum LP. RNA pathogenesis of the myotonic dystrophies. Neuromuscul Disord 2005;15:5-16   DOI   ScienceOn
28 Geifman-Holtzman O, Fay K. Prenatal diagnosis of congenital myotonic dystrophy and counseling of the pregnant mother: case report and literature review. Am J Med Genet 1998;78:250-3   DOI   ScienceOn
29 Harper PS, DG M. Myotonic dystrophy, in Engel AG, Franzini- Armstrong C (eds): Myology (ed3). In. New York: NY, McGraw Hill Professional, 2004:1039-76